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How this fits in:  
The PACE randomised controlled trial found that a C-reactive protein point-of care test 
(CRP-POCT) management strategy resulted in a 20% reduction in patient-reported 
antibiotic consumption over four weeks following consultations for AECOPD in 
primary care.   
Understanding the perceived value of CRP-POCT to clinicians and patients, potential 
mechanisms, and identifying barriers and facilitators to its use is vital in informing 
implementation plans.   
Our study indicated that the CRP-POCT had high acceptability for use in the 
management of acute exacerbations of COPD in general practice, increasing clinician 
confidence, reducing decisional uncertainty, and as a tool to facilitate communication 
and patient education.  
General Practitioners should consider adopting CRP-POCT in the routine management 
of acute exacerbations of COPD, but commissioning arrangements and further 
simplification of the point-of-care test need attention to facilitate this. 
 
Abstract 
Background: Antibiotics are prescribed to over 70% of patients presenting in primary 
care with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). 
The PACE randomised controlled trial found that a C-reactive protein point-of care test 
(CRP-POCT) management strategy resulted in a 20% reduction in patient-reported 
antibiotic consumption over four weeks following consultations for AECOPD in 
primary care.   
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Aim: To understand perceptions of the value of CRP-POCT for guiding antibiotic 
prescribing for AECOPD; explore possible mechanisms, mediators, and pathways 
through which the intervention had its effects, and; identify potential barriers and 
facilitators to implementation from the perspectives of patients and clinicians. 
Design and setting: Qualitative process evaluation in UK general practices.   
Method: Semi-structured telephone interviews with 20 patients presenting with an 
AECOPD and 20 primary care staff, purposively sampled from the PACE study. 
Interviews were audio-recorded, transcribed, and analysed using framework analysis.  
Results: Patients and clinicians felt that CRP-POCT was useful in guiding clinicians’ 
decisions about prescribing antibiotics for AECOPD, and were positive about 
introduction of the test in routine care. The CRP-POCT enhanced clinician confidence 
in antibiotic prescribing decisions, reduced decisional ambiguity, and facilitated 
communication with patients. Some clinicians thought the CRP-POCT should be 
routinely used in consultations for AECOPD, others favoured use only when there was 
decisional uncertainty. CRP-POCT cartridge preparation time and cost were potential 
barriers to implementation.  
Conclusions: CRP-POCT guided antibiotic prescribing for AECOPD had high 
acceptability, but commissioning arrangements and further simplification of the point-
of-care test need attention to facilitate implementation in routine practice.  
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Introduction 
A multi-national study found that 79% of patients presenting in primary care with an 
acute exacerbation of chronic obstructive pulmonary disease (AECOPD) were 
prescribed an antibiotic, ranging from 49% of patients in Denmark to 93% of patients 
in Russia (1). However, antibiotics are unlikely to provide meaningful benefit for most 
outpatients with AECOPD (2). Unnecessary use of antibiotics increases the threat to 
society from antibiotic resistance, and increases individual patients’ risk of side-effects 
and carriage of resistant organisms in their lungs that may in turn increase risk of 
subsequent exacerbations and disease progression (3-6).  
 
Current guidelines recommend using symptoms as the main guide to making antibiotic 
prescribing decisions for AECOPD (7, 8). C-reactive protein (CRP) is an acute phase 
reactant and raised levels are associated with AECOPD (1, 9). The PACE Study 
randomised 653 participants at 86 General Practices in the United Kingdom to 
establish whether CRP point-of-care testing (CRP-POCT) could safely reduce 
antibiotic consumption for AECOPD (10). The PACE study found that use of CRP-
POCT and guidance on interpretation of the test in primary care led to a 20%  
reduction in the consumption of antibiotics over the four weeks following consultation 
for an AECOPD, without compromising recovery at two weeks post-consultation 
compared to usual care (11).  
 
Process evaluations are an important part of evaluating complex interventions, 
providing a better understanding of the implementation and receipt of interventions 
and the context in which they were delivered (12, 13). This qualitative process 
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evaluation was embedded within the PACE study (10, 11) to better understand the 
acceptability of CRP-POCT guided antibiotic prescribing for AECOPD; explore 
possible mechanisms, mediators, and pathways through which the intervention had the 
effects observed in the quantitative component of the study (11), and; identify potential 
barriers and facilitators to implementation from the perspectives of patients and 
clinicians.  
Method 
Setting and participants 
We used a purposeful sampling method using pre-defined criterion (14, 15) to select 20 
patients in the CRP-POCT trial arm of the PACE Study, and 20 members of primary 
care teams who had carried out the CRP-POCT with patients or had used the CRP-
POCT result during patient consultations to guide their prescribing decision (i.e. where 
the CRP-POCT had been carried out by another member of the primary care team). 
The sampling framework was designed to ensure representation from patients and 
primary care teams in each of the regions where the PACE study centres were located 
(Wales, Oxford, London and Norfolk), and from patients who had, and had not, been 
prescribed antibiotics at their initial consultation. Patients who had provided consent to 
be contacted about an interview at the start of the study were contacted by telephone.  
As part of the PACE Study, primary care staff were provided with brief training in use 
of the CRP-POCT and guidance on interpretation and use of the CRP-POCT test result. 
The CRP-POCT was used in addition to usual best practice, with the test result being 
used to guide – but not mandate - antibiotic prescribing. The guidance stated that 
people with a CRP-POCT reading of <20 would probably not benefit from antibiotics, 
between 20 and 40 may benefit from antibiotics, and that antibiotics are likely to be 
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beneficial for those with a reading of >40. Full details are provided in the trial protocol 
(10).  
The PACE study adopted a pragmatic approach to implementation of the CRP-POCT, 
allowing primary care practices to arrange for the test to be conducted in way that 
fitted with their own structure and processes (10). This meant that staff other than the 
doctor, including nurses, healthcare assistants, and research assistants with appropriate 
training sometimes undertook the CRP-POCT testing. We included some of these 
individuals in the interviews to see how the test was used in these different contexts. 
The PACE Study was granted ethical approval by the Research Ethics Committee 
(REC) For Wales (Wales REC 6). Written informed consent was obtained from all 
patients. Primary care staff provided verbal consent, which was audio-recorded. Patient 
participants were sent a £10 gift voucher after their interview as a gesture of 
appreciation for their time. Primary care staff were not provided with incentives for 
participation in qualitative interviews, as they completed these as part of their wider 
involvement in the PACE Study research activities.  
 
Approach 
Flexible topic guides were used to guide interviews. The topic guides were piloted with 
patients (n=10) and primary care staff (n=9) and refined prior to use in this study. 
Interviews were audio-recorded and field notes were made. Transcripts were not 
returned to participants for comment and no repeat interviews were carried out. 
Interviews were carried out by experienced qualitative interviewers employed on the 
PACE study (HS, BSc, ASM, PhD). Their role as non-clinical researchers was 
explained to interview participants. Interviewers had no prior relationship with 
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participants. Researchers were provided with study specific training and supervision by 
an experienced qualitative researcher (RP, PhD).  
 
Analysis 
Interviews were transcribed verbatim. NVivo 11 qualitative analysis software was used 
to assist coding and facilitate analysis. Data were analysed using framework analysis, a 
systematic approach to a thematic analysis that allows for easy comparisons between 
and within cases, facilitates sharing and discussion of data, and allows for clear linking 
of developed themes to original data (16-18). The data were analysed using a hybrid 
inductive and deductive approach, based primarily on social phenomenology (19). The 
framework analysis (familiarisation, development of framework, and charting) took 
place before the trial outcomes were known, in line with the MRC guidance on process 
evaluation (12). HS carried out the data coding. Our protocol did not include dual 
coding of the data. Instead, we used regular qualitative research team meetings with 
the Trial Management Group at key junctures in the analysis to discuss data 
production, the development of the coding framework, and data analysis. This 
approach has been identified as appropriate in qualitative research (20). The definition 
of data saturation used in this study was the point at which the ability to obtain 
additional new information had been attained, and when further coding was not 
feasible (21). The qualitative researchers (RP & HS) assessed whether the last five 
interviews with primary care staff and patients provided new information that would 
add to the thematic framework being developed. On this basis, the judgement was 
made that data saturation had been achieved.  
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Results 
Interview participant characteristics are shown in Table 1. Semi-structured interviews 
were conducted with 20 clinicians and other primary care staff that undertook CRP-
POCT testing, across 19 practices. Of the 47 primary care practices that were invited to 
participate, two declined, two were unable to take part as they had not randomised any 
participants to the CRP-POCT arm, and 24 did not respond. Antibiotic prescribing rate 
were similar in practices who did (56.1%) and did not (60%) take part in the qualitative 
interviews. 
Interviews were carried out with 20 patients across four centres (Wales, Oxford, 
London and Norfolk). Of the 40 patients invited to take part in an interview, 16 
declined, one was in hospital when telephoned, and two were interested but unable to 
arrange a suitable time for an interview. A participant from the control arm of the trial 
was recruited for the interviews erroneously and their data was not included in this 
analysis.  HS or ASM conducted one-to-one interviews between October 2015 and 
March 2017. A practice manager briefly joined the discussion part way through one 
interview with a clinician. Patient interviews lasted between 15 and 35 minutes; 
primary care staff interviews lasted between 20 and 45 minutes.  
 
Framework analysis 
Key themes identified through the framework analysis related to: 1) perceptions of the 
value of the CRP-POCT, 2) possible mechanisms of impact of the CRP-POCT, and 3) 
implementation of the CRP-POCT in routine practice. A summary of key findings is 
provided in Table 2.  
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1. Perceptions of the value of the CRP-POCT 
While clinicians felt the CRP-POCT provided useful information, several felt this only 
affected their decision when there was uncertainty about whether antibiotics were 
needed. They emphasised the importance of using clinical findings to guide antibiotic 
prescribing decisions, and did not view the CRP-POCT as a replacement for clinical 
skills: 
 
“It’s shown that we’re not always right when we listen in, you know. There is a 
possibility that this may just be a viral crackle, as opposed to bacterial, but 
again it’s very difficult without the reassurance of the, the CRP, to let the 
patient go away.”  
(Nurse Practitioner 1) 
 
Clinicians talked about the added value of the test, as demonstrated by this clinician 
who described a case where a CRP reading had been unexpectedly high:  
“I told my partner, who had seen this gentleman first this morning and I told 
him how high the CRP was. He was, he was as shocked as I was. Now it may be 
that this man has another reason for having a high CRP, you know, there may 
be something else going on other than infection and we’re going to follow that 
up. But, but I would say that it would be, you know, the point of care testing 
would be an excellent thing to have in the surgery, because it can, you know, it 
can give you some information which, which you would not have on a clinical 
examination.”  
(General Practitioner 1) 
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Primary care staff felt that the CRP-POCT reassured patients, and that the test 
demonstrated to patients that a thorough examination had taken place:  
“They [patients] feel reassured that no antibiotics have been given and the 
doctor’s actually checked that this was not necessary before he said “no” to 
the antibiotics, rather than just saying “no you don’t need it”” 
(General Practitioner 2) 
 
Clinicians were aware of the need to reduce antibiotic prescribing, and felt that the 
perceived risk of under-treatment was a driver for prescribing unnecessary antibiotics 
for AECOPD.  
“There’s so much pressure not to refer patients to hospital, so if you, the view 
is, if you treat them early, you know, when their symptoms are relatively mild, 
maybe we’ll be able to stop someone going to hospital unnecessarily” 
       (General Practitioner 3) 
 
The perception that early prescribing can reduce hospitalisation is at odds with 
evidence from a Cochrane review which did not find evidence that antibiotic 
prescribing for AECOPD in outpatient settings has an effect on hospital admissions or 
mortality. A GP also raised the issue of fear of litigation, where the CRP-POCT was 
seen as providing objective evidence to help justify prescribing decisions.  
 
“I can only speak for myself, but every patient I see, when I’m writing down, I’m 
thinking that somebody’s going to be suing me as a result of it, which is very sad 
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but it’s just the way the world’s going, and I think every GP is probably very 
similar, and I know that if I write down “CRP less than 5” then anyone taking me 
to court over that is going to have one hell of a hard time of it to prove that that 
patient was ill at that point.” 
(General Practitioner 5) 
 
Patients felt the CRP-POCT could ‘help’ doctors with their decisions, and did not 
report any anxiety about having the test. Patients felt that the CRP-POCT was useful in 
rapidly deducing the severity of illness and/or need for antibiotics:  
“I think it’s a great idea to measure really sort of how ill you are and whether 
you really need more treatment or not” 
     (Patient 1, female, CRP <20, no antibiotics) 
2. Perceived mechanisms of impact of the CRP-POCT 
Three sub-themes were identified relating to perceptions about how the use of the 
CRP-POCT might achieve the desired aim of safely reducing antibiotic use: the CRP-
POCT as an objective sign of illness; use of the CRP-POCT to enhance patient-
clinician communication, and; use of the CRP-POCT to reinforce the prescriber’s 
decision.   
 
The CRP-POCT provided an objective sign of illness severity 
Prescribers reported that the CRP-POCT reading provided objective evidence to 
support clinical decision-making and reduce decisional uncertainty.  
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“I think the clinical decision was, was probably there anyway without needing 
the CRP test, but obviously there are some instances where, you know, if you’re 
not too sure, then obviously that CRP test could’ve maybe made that difference 
as to whether you gave the antibiotics or not”  
(Non-prescriber 1) 
 
Being able to share the reading with patients helped to provide objective evidence to 
provide support for treatment decisions when communicating with patients. 
“Because I think if it’s just you face-to-face and you have no objective 
evidence, it’s just your opinion and they sometimes question that.”  
 (General Practitioner 4) 
 
Clinicians felt that the CRP-POCT enhanced their confidence and reassured both 
prescribers and patients about their decision with regard to antibiotic treatment.  
“I found writing down ‘CRP normal’, I found that that was a very powerful way 
of reassuring me and the patient actually, it seemed to place a great deal of, 
you know, faith on, on blood testing”  
(General Practitioner 5) 
 
Many patients viewed the CRP-POCT as a useful way of objectively measuring the 
severity of their illness:  
“I thought it [the CRP-POCT] was excellent because it was just proving what I 
already knew if you know what I mean” 
   (Patient 2, female, CRP 20-40, prescribed antibiotics) 
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However, one patient viewed the CRP-POCT negatively as they felt that the test result 
was not consistent with their subjective experience.  
“I wasn’t happy to be honest, because, simply because they said the test that 
was OK and [I had] an ever [so] slight inflammation which they took because 
of this blood test she found and she gave me five days of the steroids, but after 
the five days I was back to square one.” 
    (Patient 3, male, CRP <20, no antibiotics)  
The CRP-POCT enhanced physician-patient communication  
Clinicians felt that patients had greater involvement in the consultation through 
discussion of the test outcome, and that it provided them with an opportunity to talk to 
patients about antibiotic stewardship:   
“It allows you to talk a little bit about antibiotics, you can then, you can, we 
can then add and refer people to an information sheet about the duration of 
common symptoms for example”  
(General Practitioner 3) 
 
From the patient perspective, there was a reasonable level of understanding of the 
purpose of the CRP-POCT in terms of guiding doctors’ antibiotic prescribing 
decisions.  
“Yes, it was to see if I had an infection on my chest and the count of it was I 
think five, so they decided I didn’t have an infection but that the steroids would 
help me, which they did” 
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    (Patient 4, female, CRP<20, no antibiotics) 
 
Nonetheless, some patients were uncertain about what the CRP-POCT was testing, and 
there were some misconceptions about the type of infection that would require 
antibiotic treatment. 
“They need to confirm, which is what I thought this test and that was doing, 
that it is, it is a proper viral infection” 
   (Patient 5, male, CRP 20-40, prescribed antibiotics) 
 
CRP-POCT reinforced prescribers’ decisions 
The CRP-POCT reading was generally used by clinicians to articulate and justify their 
prescribing decisions. 
“It gives something to justify to the patient that it’s not just your clinical 
judgement on the signs and things. That you have actually done a test and that 
has, you know, given even more back up that the fact that you confidently don’t 
need antibiotics.”  
(General Practitioner 6) 
 
Patients felt that their prescribers were, and should be, the decision-makers with regard 
to antibiotic treatment.  
 “Well I don’t think it comes under what the patients want, it’s the patient is ill 
enough to need antibiotics, you know then they should be given. Other than that 
I don’t think they should be given, if the patient isn’t ill enough for them.”  
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(Patient 6, female, CRP<20, no antibiotics) 
 
Patients who perceived being involved in decision making about antibiotic prescription 
described this in terms of their agreeing with the doctor’s decision and having 
confidence in their expertise or because they felt that the doctors had explained their 
decision to them, rather than being actively involved in the decision-making process 
per sé.  
“I would say my doctors give me sound advice about what to do, because at the 
end of the day I know they are very busy people and their range of knowledge is 
quite astounding, and at the end of the day I’m relying on him to give me the 
correct information to make an educated decision”  
   (Patient 7, male, CRP<20, prescribed antibiotics) 
 
3. Implementation of the CRP-POCT  
Views about implementation in routine practice 
Patients and primary care staff had a positive view about whether the CRP-POCT 
should be introduced into routine National Health Service (NHS) care for patients with 
AECOPD.  
“I think it’s an important test and if we, it’s something I’d certainly want to 
explore in the future after the trial is finished, getting a CRP machine for the 
practice”  
(General Practitioner 7) 
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Primary care staff discussed the advantages of using the test in routine care mainly in 
terms of antibiotic stewardship and achieving more consistent prescribing decisions:  
“So I think it may help to standardise the treatments that we offer, I definitely 
think it’s a good idea, I think it’s something that we should be doing more of, 
because I think we probably would end up prescribing less antibiotics because 
of it.”  
(Nurse Practitioner 2)  
 
Patients discussed the benefits of the test mainly in terms of reducing antibiotic use and 
saving money. From the patient perspective, their priority when they had an AECOPD 
was to resolve their symptoms. There were mixed feelings about when antibiotics 
should be prescribed. Mostly, patients recognised how valuable antibiotics were when 
they were needed, but did not want to take them if they weren’t required.  
“It’s not good taking antibiotics just for a minor complaint, you know, you 
should have it being really bad with your chest before taking antibiotics” 
    (Patient 6, female, CRP<20, no antibiotics) 
 
Within this context, they were receptive to the use of the CRP-POCT in routine care.  
“I think they’re [GPs] doing their best, and I do think that the pinprick test is 
absolutely amazing and I should … I would like it to be done as a regular thing 
if you get a flare up.”  
(Patient 4, female, CRP<20, not prescribed antibiotics)  
Clinicians and other primary care staff had mixed views on how the test should be 
implemented. Some clinicians felt that using the CRP-POCT for all patients presenting 
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with AECOPD to ‘increase their data’, provided a learning tool to improve their ability 
to detect patients who need antibiotic treatment. Others felt they would only use the 
CRP-POCT when there was decisional uncertainty about the need for antibiotics.  
 
Technical aspects of the CRP-POCT 
Patients did not report any difficulties with the use of the CRP-POCT by clinicians. 
Primary care staff reported being able to use the CRP-POCT with all patients 
randomised to the intervention arm, and in general the CRP-POCT was easy to use. 
The need to refrigerate cartridges and allow time for them to return to room 
temperature before use, and the need to regularly carry out control testing, were seen as 
burdensome and were potential barriers to implementation. Clinicians felt that some 
modifications to the technology would facilitate implementation.  
“I think that, you know, in theory that [using the CRP-POCT in routine care] 
could be very good, but the only thing I would say is that because it’s so 
cumbersome within the consultation clinicians won’t use it, I’m just being 
honest with you, it takes, you know, 10 minutes to go and sort the machine and 
calibrate it, you know, how easy is that going to be?”  
(General Practitioner 8) 
“I think it would be nicer if it was, you know in and ideal world, if it was a 
hand held machine, so you could take it with you on a, on a home visit for 
instance, would be a useful”  
(General Practitioner 7) 
Time & resources 
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Patients felt that use of the test was quick.  The primary care staff felt that using the 
CRP-POCT made consultations slightly longer, but felt that this was a good investment 
of their time: 
“I think where there was a great degree of uncertainty about what the right 
thing was to do, yeah there are definitely times when you’d be willing to invest 
that extra bit of time to do it.”  
(General Practitioner 9)  
 
Primary care staff felt that the cost of the CRP-POCT machine and cartridges was 
prohibitive under their current funding arrangements, and it would not be widely 
adopted unless additional funding was provided to cover these costs.  
 
Contextual factors that could influence the way the CRP-POCT is implemented 
Patient attitudes with regard to antibiotic use for AECOPD were varied, but many did 
not want to take antibiotics for AECOPD unless they were required. Patient anxiety, a 
strong patient preference for antibiotics, and individual circumstances (e.g. recent 
death of a spouse) were cited by primary care staff as reasons for still prescribing 
antibiotics despite a low CRP-POCT result, indicating that non-medical factors 
continued to influence antibiotic prescribing.  
 
Discussion 
Summary 
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We found that patients and clinicians considered CRP-POCT useful in guiding 
management of AECOPD by providing an indication of disease severity, facilitating 
communication with patients and managing their expectations, and increasing clinician 
and patient confidence in antibiotic prescribing decisions. Previous research identified 
difficulties with interpreting the implications of CRP results and concerns about 
distracting from clinical reasoning as perceived barriers to implementing CRP-POCTs 
(22). In the PACE study, clinicians were given guidance on the interpretation of the 
CRP-POCT result and were asked to use the CRP-POCT with all patients randomised 
to the CRP-POCT trial arm. Our clinician respondents did not report difficulties in 
interpreting the CRP-POCT or any negative impact on their clinical judgement. 
Likewise, our patient respondents felt the CRP-POCT was useful in guiding their 
doctors’ antibiotic prescribing decisions and felt that it would be acceptable for use in 
routine care.  
 
Strengths and limitations 
General practitioners and patients who agreed to participate in the trial may have more 
favourable views about this technology than those who did not agree to participate. 
Nonetheless, the interview participants were purposively sampled using a maximum 
variation approach to ensure that we captured a range of views, and our findings are 
therefore likely to be representative of those that would be willing to consider use of 
the test. Approximately 50% of practices and 40% of patients invited for interviews in 
the current study declined or did not respond, thus self-selection to the interviews may 
also have introduced a sampling bias. An implementation study involving a wider roll-
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out of the intervention would be required to investigate to what extent the findings our 
study generalise to a broader population.   
 
Comparison with existing literature 
Patients with COPD are at risk of developing frequent and severe respiratory infections 
that can have a long-term impact on their lung function (23), and in this sense are a 
higher risk group than those presenting with uncomplicated acute cough presenting in 
primary care. Nonetheless, clinicians and patients in our study expressed similar views 
of the use of CRP-POCT to guide antibiotic prescribing as those that have been 
reported in studies of acute cough (22, 24-29). Potential benefits to using CRP-POCT 
routinely include improved opportunity for early intervention, reduced hospital 
admissions, and reducing unnecessary use of antibiotics by improving diagnostic 
confidence and improving communication with patients (24, 30, 31).  
 
CRP-POCTs are widely used in a number of European countries in the management of 
LRTIs, but have not yet become routinely used in the UK (30). The absence of a 
funding and reimbursement model has been identified as the primary barrier for 
widespread adoption of the CRP-POCT for acute cough in the NHS (30). This concern 
was shared by the clinicians we interviewed in the PACE study and should be 
addressed by commissioners and policy makers to enable implementation of the CRP-
POCT in routine care for AECOPD.   
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Previous research has suggested that risk aversion and the perception that the CRP-
POCT time consuming are potential barriers to its adoption (30). In our study, 
clinicians felt that the CRP-POCT would reduce risk to patients through better 
targeting of antibiotics, and as such the time invested in carrying out the test was 
worthwhile. In European countries where CRP-POCT is routinely used for acute 
cough, typical patient pathways for CRP-POCT include GPs or practice nurses 
carrying out the CRP-POCT during their consultations with patients (30). Other 
appropriately trained members of primary care teams can complete the CRP-POCT 
and pass the information on to prescribing clinicians (30). In the PACE study, practices 
could use any of these options to enable them to adapt the implementation of the CRP-
POCT to fit with their practice routines (10). Clinicians had mixed views on how the 
CRP-POCT should be implemented in terms of whether it should be used with all 
patients, or only in cases where there was clinical uncertainty. Guidance for clinicians 
will be required in introducing CRP-POCT in routine practice for AECOPD to 
facilitate its implementation in a consistent and effective way.  
 
The PACE trial found reduced antibiotic prescribing for AECOPD from CRP-POCT 
use. Nevertheless, antibiotics were prescribed for 33% of patients who had a CRP-
POCT level of <20mg, where guidance indicated that antibiotics were unlikely to be of 
benefit (11). Non-clinical contextual factors, such patient expectations for antibiotics, 
access to antibiotics before consulting with a clinician, and a lack of clear guidelines 
can influence clinicians’ antibiotic prescribing behaviour for acute cough (32). Being 
able to effectively elicit patient ideas, concerns, expectations, and beliefs is an 
important skill for clinicians managing acute cough (27, 33, 34). There was a 
perception amongst some patients that the CRP-POCT provided an accurate indication 
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on ‘how ill’ they were, as well some misconceptions around the necessity of antibiotics 
for bacterial and viral infections. Providing patients with more information about the 
function of the test and effective management of exacerbations may therefore be of 
benefit. In acute cough, a combination of training use of a CRP-POCT and enhanced 
communication-skills training has a larger effect than either form of training alone 
(34). Additional training for clinicians in integrating the CRP-POCT into consultations 
in a patient-centred way and enhanced information for patients about the purpose and 
potential benefits of testing might facilitate adoption. 
 
Implications for practice 
Patients and clinicians reported that the CRP-POCT led to less clinical uncertainty, 
increased prescribing confidence, and enhanced communication. These were all 
potential mechanisms for a safe reduction in overall antibiotic use for AECOPD.  Both 
patients and clinicians emphasised the need to use the CRP-POCT as part of, not in 
place of a high-quality consultation that includes a clinical examination, elicitation of 
patient views and preferences, the application of the prescriber’s clinical judgement, 
and information on how and when patients should re-consult if they are not recovering 
as expected. Taken together with the quantitative findings from our trial (11), the 
findings of this study suggest that practitioners should consider adopting CRP-POCT 
in the routine management of AECOPD. Implementation planning for the CRP-POCT 
should include consideration of funding arrangements, simplifying the CRP-POCT 
technology so that it is quicker and easier to use, guidelines on implementation of the 
test for clinicians, and better information for patients.  
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Table 1: Characteristics of qualitative process evaluation participants  
Patients N Prescribed antibiotics 
at index consultation 
(n) 
Not prescribed 
antibiotics at index 
consultation (n) 
CRP reading <20 14 4 10 
CRP reading >20 6 5 1 
Total patients 20 9 11 
Primary care staff N Made prescribing 
decisions guided by 
CRP-POCT result (n) 
Carried out the 
CRP-POCT (n) 
General Practitioners 12 12 7 
Nurse Practitioners 5 5 5 
Non-
prescribers  
Practice nurse 1 0 1 
Research 
assistant 
1 0 1 
Pharmacist 1 0 1 
Total primary care staff 20 17 15 
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Table 2: Summary of key themes extracted from the qualitative interviews 
Main theme Sub-theme Patient views Primary care staff views 
Perception of 
the value of the 
CRP-POCT 
General views of 
the CRP-POCT 
Many felt that the CRP-POCT was a useful addition to the 
consultation that would help guide their doctor’s antibiotic 
prescribing decision. 
Most thought the CRP-POCT was a useful addition to the consultation, 
particularly where there was diagnostic uncertainty. Clinicians 
emphasised the importance of using the CRP-POCT in addition to, not in 
place of, a thorough clinical assessment. 
Perceived 
mechanisms of 
impact of the 
CRP-POCT 
Objective sign of 
illness 
Patients felt that the CRP-POCT provided an objective sign 
of illness severity that could help guide treatment.  
Prescribers felt that having this additional piece of objective evidence 
increased their confidence in their antibiotic prescribing decisions.   
Enhancing 
patient-clinician 
communication 
CRP-POCT useful in understanding whether antibiotics are 
needed, but some misconceptions about when antibiotics 
might or might not be helpful (e.g. for viral infections).   
Primary care staff felt that the test provided an opportunity to open 
discussions with patients about antibiotic use and antimicrobial 
resistance. 
Reinforcing 
prescribers’ 
decisions 
Patients were generally passive in terms of making decisions 
about antibiotic treatment, with clinicians explaining their 
decision to/not to prescribe antibiotics to them. 
Primary care staff perceived the CRP-POCT result as being useful in 
reinforcing their decision about antibiotic prescribing when 
communicating with patients. 
Implementation 
of the CRP-
POCT 
Views about 
implementation in 
routine practice 
Many patients expressed positive attitudes towards the use 
of the CRP-POCT in routine NHS care for the management 
of AECOPD.  
Positive attitudes towards the use of the CRP-POCT in routine NHS care, 
but there were differences of opinion about whether the CRP-POCT 
would be used for all patients with AECOPD, or only those where there 
was clinical uncertainty.  
Technical aspects 
of the test 
Patients did not report any difficulties with the use of the 
CRP-POCT by clinicians.  
Found the CRP-POCT easy to use, but felt that the need for test cartridges 
to be refrigerated during storage and returned to room temperature before 
use, need for regular calibration of the machine, and lack of portability of 
the device were potential barriers to widespread use in primary care.   
Time & resources Patients felt that use of the test was quick, didn’t report any 
problems with administration of the test.   
 
Acknowledged the impact on consultation length that use of the CRP-
POCT had, but felt that it was worthwhile. Felt that the cost of the CRP-
POCT machine and cartridges was prohibitive under current funding 
arrangements. 
Contextual 
factors 
Non-medical 
factors that 
influenced 
prescribing 
Patient attitudes with regard to antibiotic use for AECOPD 
were varied, but many did not want to take antibiotics for 
AECOPD unless they were required.  
Patient anxiety, a strong patient preference for antibiotics, and individual 
circumstances (e.g. recent death of a spouse) were cited by primary care 
staff as reasons for still prescribing antibiotics despite a low CRP-POCT 
result 
 
